Savant Capital, LLC Viatris Inc Transaction History
Savant Capital, LLC
- $17.8 Billion
- Q3 2025
A detailed history of Savant Capital, LLC transactions in Viatris Inc stock. As of the latest transaction made, Savant Capital, LLC holds 33,029 shares of VTRS stock, worth $354,070. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,029
Previous 18,769
75.98%
Holding current value
$354,070
Previous $167,000
95.21%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding VTRS
# of Institutions
1,132Shares Held
967MCall Options Held
7.74MPut Options Held
2.47M-
Vanguard Group Inc Valley Forge, PA140MShares$1.5 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$993 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD84.1MShares$901 Million0.09% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az69.3MShares$743 Million3.68% of portfolio
-
State Street Corp Boston, MA55.7MShares$597 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...